Fractional CO2 Treatment of Acne Scars in Asians

• The objective of this study is to investigate the efficacy and side effects of a fractional CO2 laser for treatment of acne scar in Asians.
• Study hypothesis

• Reduction in acne scars based on blinded evaluation of before photos and the one and three month follow-up photos after four full face Ellipse Juvia with low density treatments with a fluency of 90-105 mJ/MTZ is statistically significant (5%).
• The direct clinical blinded evaluated reduction in acne scars based on before photos and the patient in life, by the one and three month follow-up is statistically significant (5%)
• Reduction in fine lines based on blinded evaluation of before photos and the one and three month follow-up photos after four full face Ellipse Juvia with low density treatments with a fluency of 90-105 mJ/MTZ is statistically significant (5%).
• The direct clinical blinded evaluated reduction in fine lines based on before photos and the patient in life, by the one and three month follow-up is statistically significant (5%).
• Reduction in pigmented disorders based on blinded evaluation of before photos and the one and three month follow-up photos after four full face Ellipse Juvia with low density treatments with a fluency of 90-105 mJ/MTZ is statistically significant (5%).
• The direct clinical blinded evaluated reduction in pigmented disorders based on before photos and the patient in life, by the one and three month follow-up is statistically significant (5%).
• Improvements in skin texture and pore size based on blinded evaluation of before photos and the one and three month follow-up photos after four full face Ellipse Juvia with low density treatments with a fluency of 90-105 mJ/MTZ is statistically significant (5%).
• The direct clinical blinded evaluated reduction in skin texture and pore size based on before photos and the patient in life, by the one and three month follow-up is statistically significant (5%).

Inclusion criteria

• Numbers of volunteers: 10 healthy men and women
• Aged at least 30 year old
• Skin type: 1 - 4
• Degree of suntan: None - light
• Skin condition: visible acne scars

Exclusion criteria

• Fitzpatrick skin types 5-6.
• Patients with lesions with any clinical suspicion of being pre-cancerous or skin malignancies of any kind.
• Patients with skin diseases associated with Koebner phenomena.
• Patients who have used Botox or filler injection to the periorbital or perioral regions 12 months prior or during the study.
• Patients who have used topical retinoids, AHA under prescription or Vitamin C, 3 months prior to or during the study.
• Patients who are pregnant or who wish to become pregnant and lactating women.
• Patients who have been exposed to sun within 2 week from date of treatment.
• Patients prone to hypertrophic scars or keloids
• Patients who have previously undergone laser resurfacing may not be suitable for yet another procedure.
• Patients undergoing oral retinoid therapy for acne in the past 6 months.
• Patients who suffer from any serious medical condition, including diabetes, bleeding diathesis, delayed wound healing or prednisolone intake.
• Patients with wound infections (herpes, other) on the day of treatment.
• Patients with moderate and severe inflammatory acne, Immunosuppressed patients, History of vitiligo.
• Patients with unrealistic concerns/expectations and inability to do the appropriate post-operative care.